Wall Street Jumps as Pharmaceuticals Soar Amid Fed Bullishness


North Carolina House Unanimously Approves Medical Marijuana Bill

US shares soared, with the Dow Jones Industrial Average hitting a record high, as pharmaceuticals rallied on deals and investors were upbeat the economy will grow faster.

Shares of healthcare firms listed in the Standard & Poor’s Index surged 0.8% in the wake of a takeover bid for Shire Plc. CarMax Inc added 18% after three-month results beat projections as improved customer traffic propelled car sales. Oracle Corp lost 4.4% after announcing profits and sales that were below analysts’ forecasts.

The S&P 500 soared to 1,961.19 as of 1:25 pm in New York. The stocks gauge has risen for six days in a row, its longest rally since April. The Dow won 19.62 or 0.1% to 16,941.08. The two indexes hit all-time peaks. The Nasdaq gained less than 0.1%.

“This is an energy bunny sort of market that wants to keep marching higher and for a good reason. The U.S. economy is showing varying signs of improvement. Earnings are rising, interest rates are low and inflation is elevated, but not at extremes,” Terry Sandven of Bank Wealth Management in Minneapolis told Bloomberg. He added that equities were facing a supportive environment to rally higher.

The volume of shares exchanged in the S&P 500 gauge was 45% higher than the average for the past 30 days as the time of the day.


Shares soared this week after Federal Reserve Chair Janet Yellen an above average growth in economy should be witnessed with a supportive monetary policy, surging prices of property and shares and the growing global economy.

Stocks at the S&P 500 are exchanging at 16.6 times the estimated earnings of its listed firms, an increase from 15.5 times at the beginning of 2014.

According to Economic Times, prices of bonds flopped. The 10-year Treasury note’s yield gained to 2.63%, up from 2.62% late Thursday.

To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.

To contact the reporter of this story; Jonathan Millet at john@forexminute.com